Standard Biotools (LAB) Shares Outstanding (2010 - 2026)

Standard Biotools (LAB) has reported Shares Outstanding (Entity) for 17 consecutive years, with $392.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 2.73% year-over-year to $392.1 million in Q2 2026; TTM through Jun 2026 was $392.1 million, a 2.73% increase from a year earlier, with the FY2025 full-year figure at $386.4 million, up 2.34% from the prior year.
• Shares Outstanding (Entity) was $392.1 million for Q2 2026 at Standard Biotools, up from $390.1 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $392.1 million in Q2 2026 and troughed at $77.2 million in Q1 2022.
• A 5-year average of $242.2 million and a median of $332.6 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) grew 0.28% in 2023 and jumped 370.55% in 2024, its largest moves.
• Over 5 years, Shares Outstanding (Entity) stood at $79.5 million in 2022, then advanced by 0.94% to $80.2 million in 2023, then soared by 370.55% to $377.5 million in 2024, then increased by 2.34% to $386.4 million in 2025, then advanced by 1.49% to $392.1 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $392.1 million (Q2 2026), $390.1 million (Q1 2026), and $386.4 million (Q4 2025), per Business Quant data.